Blau Farmacêutica S.A.
BLAU3
Rank in Stocks
#13510
Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying... Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying private label medications across Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. Its extensive product portfolio encompasses a broad spectrum of therapeutic areas, including immunology, hematology, oncology, nephrology, specialized treatments, and antibiotics. The company's offerings also extend to biological drugs, oral and injectable therapies for cancer, specialized treatments for infectious diseases, and a range of prescription and over-the-counter products like dermo-medicines and contraceptives, catering to both retail and non-retail markets. Additionally, Blau provides pharmaceuticals derived from blood, biological and biotechnological agents, and antiretroviral drugs. Its client base includes hospitals, private medical clinics, chemotherapy and hemodialysis centers, and public health institutions. Established in 1987, the firm's corporate headquarters are situated in Cotia, Brazil.
Share Price
$1.67
Last synced: 2026-11-10
Market Cap
$384.84M
Change (1 day)
0.00%
Change (1 year)
-10.19%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Blau Farmacêutica S.A. (BLAU3)
Category
Healthcare
EPS for Blau Farmacêutica S.A. (BLAU3)
EPS as of June 2026 TTM: $0.21
According to Blau Farmacêutica S.A.'s latest financial reports, its current EPS (TTM) is $0.21. At the end of 2025 the company had an EPS of $0.18, a decrease compared to its 2024 EPS of $0.20.
EPS history for Blau Farmacêutica S.A. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.21 | 15.33% |
| 2025 | $0.18 | -9.98% |
| 2024 | $0.20 | -32.07% |
| 2023 | $0.29 | -23.95% |
| 2022 | $0.38 | 17.61% |
| 2021 | $0.32 | 16.37% |
| 2020 | $0.28 | -16.86% |
| 2019 | $0.34 | 86.25% |
| 2018 | $0.18 | 1.24% |
| 2017 | $0.18 | 222.06% |
| 2016 | $0.06 | 81.91% |
| 2015 | $0.03 | -26.39% |
| 2014 | $0.04 | -2.59% |
| 2013 | $0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 3,031.70% |
DE
|
|
| $6.08 | 2,827.55% |
DE
|
|
| $1.55 | 646.92% |
JP
|
|
| $3.66 | 1,663.01% |
CH
|
|
| $0.45 | 116.76% |
IL
|
Questions about Blau Farmacêutica S.A.'s earnings per share (EPS)
What is Blau Farmacêutica S.A.'s earnings per share (EPS)?
Blau Farmacêutica S.A.'s earnings per share (EPS) over the last twelve months is $0.21, as of Jun 2026.
What was Blau Farmacêutica S.A.'s earnings per share (EPS) in 2025?
In 2025, Blau Farmacêutica S.A.'s earnings per share (EPS) was $0.18, 10.00% less than in 2024 ($0.20).
How has Blau Farmacêutica S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Blau Farmacêutica S.A.'s earnings per share (EPS) went from $0.28 to $0.18, an average decline of 8.46% a year.
How does Blau Farmacêutica S.A.'s earnings per share (EPS) compare with similar companies?
Blau Farmacêutica S.A.'s earnings per share (EPS) ($0.21) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.